Gene Expression in Breast Carcinomas: Pathogenesis (Hormone Sensitive)
Gene Expression in Breast Carcinomas: Pathogenesis (Hormone Sensitive)
Both ER subtypes carry a DNA binding domain and exist in the nucleus and the cytosol. When estrogen enters
the cell, it binds the ER and the complex migrates into the nucleus and leads to the production of transcription
proteins that induces changes in the cell. Therefore, due to estrogen’s proliferative properties, its cellular
stimulation can have negative consequences in patients expressing large quantities of these receptors
intracellularly.